home / stock / agnpf / agnpf quote
Last: | $0.09892 |
---|---|
Change Percent: | 9.31% |
Open: | $0.09 |
Close: | $0.09892 |
High: | $0.1094 |
Low: | $0.09 |
Volume: | 46,586 |
Last Trade Date Time: | 05/15/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.09892 | $0.09 | $0.09892 | $0.1094 | $0.09 | 46,586 | 05-15-2024 |
$0.09924 | $0.0788 | $0.09924 | $0.09924 | $0.0788 | 530 | 05-14-2024 |
$0.086 | $0.0891 | $0.086 | $0.0891 | $0.086 | 20,150 | 05-13-2024 |
$0.092 | $0.08224 | $0.092 | $0.092 | $0.08224 | 20,564 | 05-10-2024 |
$0.0796 | $0.083 | $0.0796 | $0.08565 | $0.0796 | 25,008 | 05-09-2024 |
$0.09025 | $0.0887 | $0.09025 | $0.09025 | $0.08595 | 73,348 | 05-08-2024 |
$0.08874 | $0.08874 | $0.08874 | $0.08874 | $0.08874 | 4,056 | 05-07-2024 |
$0.0778 | $0 | $0.0778 | $0 | $0 | 120 | 05-06-2024 |
$0.0778 | $0.08025 | $0.0778 | $0.08025 | $0.0778 | 1,044 | 05-03-2024 |
$0.08234 | $0 | $0.08234 | $0 | $0 | 68 | 05-02-2024 |
$0.08234 | $0 | $0.08234 | $0 | $0 | 40 | 05-01-2024 |
$0.08234 | $0.095 | $0.08234 | $0.095 | $0.07856 | 10,377 | 04-29-2024 |
$0.091435 | $0.0865 | $0.091435 | $0.091435 | $0.0865 | 6,040 | 04-26-2024 |
$0.0872 | $0.067 | $0.0872 | $0.0872 | $0.067 | 508 | 04-25-2024 |
$0.089 | $0.089 | $0.089 | $0.089 | $0.089 | 21,500 | 04-24-2024 |
$0.089 | $0.07885 | $0.089 | $0.089 | $0.07885 | 75,088 | 04-23-2024 |
$0.0716 | $0.0606 | $0.0716 | $0.0716 | $0.0606 | 12,208 | 04-22-2024 |
$0.0756 | $0.0639 | $0.0756 | $0.0756 | $0.0636 | 4,436 | 04-19-2024 |
$0.07083 | $0.07083 | $0.07083 | $0.07083 | $0.07083 | 1,304 | 04-18-2024 |
$0.06715 | $0.06715 | $0.06715 | $0.06715 | $0.06715 | 100 | 04-16-2024 |
News, Short Squeeze, Breakout and More Instantly...
Algernon Pharmaceuticals Inc - Class A Company Name:
AGNPF Stock Symbol:
OTCMKTS Market:
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") (CSE:AGN) (FRANKF...
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its...
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE:AGN) (FRANKFUR...